Return to Faculty

Faculty


Trang H. Au

Assistant Professor of Pharmacy Practice, Full-time

Pharm.D., Creighton University School of Pharmacy

Description

Dr. Au received her Pharm.D. from Creighton University School of Pharmacy.  She completed specialty residency training in hematology/oncology at the University of Utah Huntsman Cancer Institute and continued as a clinical pharmacist in the outpatient clinic for gastrointestinal cancers.  In addition, Dr. Au completed a 2-year post-doctoral Research Fellowship at the University of Utah, College of Pharmacy.  Her academic interests involve teaching and mentoring students, as well as conducting research across a broad range of cancers with an emphasis on data-driven, real-world patient outcomes. 


Specialties

Internal medicine

Hematology/Oncology

Publications

Stenehjem DD, Au T, Sainski AM, Bauer H, Brown K, Lancaster J, Stevens V, Brixner DI. Impact of a genetic counseling requirement prior to genetic testing. BMC Health Serv Res. 2018 Mar 7;18(1):i6357. 

Au TH, Stenehjem DD, Garrido-Laguna I. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies. J Gastrointest Oncol. 2017 Jun;8(3):387-404.

Au TH, Cavalieri CC, Stenehjem DD. Ceritinib: A Primer for Pharmacists. J Oncol Pharm Pract. 2016. Oct 13


Lectures and Presentations

Can Precision Medicine Tame the High Cost of Cancer Drugs? University of Utah Second Annual Precision Medicine Symposium. Salt Lake City, UT. Dec 2, 2016.

Managing Toxicities of Oral Antineoplastic Therapies. California Society of Health-System Pharmacists Seminar. Anaheim, CA. Oct 27, 2016.

Breast Cancer. Hematology/Oncology Pharmacy Residents Seminar. Huntsman Cancer Institute, University of Utah. Salt Lake City, UT. Dec 1, 2015.


Exhibits

Au TH, Bauer H, Ma J, Nelson R, Watanabe A, Singh P, Korytowsky B, Wilson E, Willmarth N, Cohen A, Colman H, Stenehjem D, Brixner D. Development of a novel burden survey for caregivers of glioblastoma multiforme (GBM) patients. Society for Neuro-oncology Annual Meeting. San Francisco, CA. Nov 15-16, 2017.

Biltaji E, Au TH, Walker B, Ose J,Ulrich CM, Stenehjem D, Brixner, D. Cost Threshold Analysis of Genotype-Guided Aspirin Use for Colorectal Cancer Prevention. ISPOR 22nd Annual International Meeting. Boston, MA. May 20-24, 2017.

Biltaji E, Au TH, Gligorich K, Bronner MP, Stenehjem DD, Brixnr DI. Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts. ASCO Quality Care Symposium. Orlando, FL. Mar 3-4, 2017.

Au TH, Bailey EB, Patel S, Tantravahi S, Agarwal N, Stenehjem D. Risk of hepatotoxicity with concurrent statin and tyrosine kinase inhibitor (TKI) or mTOR inhibitor (mTORi) in patients with metastatic renal cell carcinoma (mRCC). American Society of Clinical Oncology Genitourinary Cancers Symposium. San Francisco, CA. Jan 2016.

Au TH, Bailey EB, Patel S, Tantravahi S, Agarwal N, Stenehjem D. Effect of concomitant proton pump inhibitor (PPI) on effectiveness of tyrosine kinase inhibitor (TKI) in patients with metastatic renal cell carcinoma (mRCC). American Society of Clinical Oncology Genitourinary Cancers Symposium. San Francisco, CA. Jan 2016.


American Society of Clinical Oncology

Hematology/Oncology Pharmacy Association

American College of Clinical Pharmacy